UCB S.A.: Restless Legs Syndrome trials

The registry lists 17 Restless Legs Syndrome studies with UCB S.A. as lead sponsor. 0 are open to participants now and 11 have results posted.

Phase 2 5Phase 3 9Phase 4 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs SyndromeTerminatedNCT03992196Phase 3Results posted
• A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown CauseTerminatedNCT03728933Phase 3Results posted
• Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)CompletedNCT01569464Phase 3Results posted
• A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring HemodialysisCompletedNCT01537042Phase 3Results posted
• Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs SyndromeCompletedNCT01498120Phase 2Results posted
• Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs SyndromeCompletedNCT01495793Phase 2Results posted
• Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs SyndromeCompletedNCT01455012Phase 4Results posted
• Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced AugmentationCompletedNCT01386944Results posted
• Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily PractiseCompletedNCT01113710Results posted
• Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)CompletedNCT00498186Phase 2Results posted
• Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS SymptomsCompletedNCT00389831Phase 2Results posted
• Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome SubjectsCompletedNCT00498108Phase 3
• A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs SyndromeCompletedNCT00275236Phase 3
• An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs SyndromeCompletedNCT00263068Phase 3
• Rotigotine Restless Legs Syndrome Dose Finding TrialCompletedNCT00243217Phase 2
• Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg SyndromeCompletedNCT00136045Phase 3
• Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs SyndromeCompletedNCT00135993Phase 3